11 June 2026
Latham Represents GT Medical Technologies in Oversubscribed US$100 Million Series E Equity Financing
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Luke Bergstrom Lead | Latham & Watkins LLP | Partner | Emerging Companies & Growth | Bay Area |
| Omar Ammash | Latham & Watkins LLP | Associate | Emerging Companies & Growth | Not stated |
| Erica Kucharski | Latham & Watkins LLP | Associate | Emerging Companies & Growth | Not stated |
| Farah Arif | Latham & Watkins LLP | Associate | Emerging Companies & Growth | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 100m (US$100 million)
- What the figure measures
- Issue size
- Client
- GT Medical Technologies, Inc.Issuer
- Counterparties
- Viking Global Investors (Investor)
MVM Partners (Investor)
Gilde Healthcare (Investor)
Evidity Health Capital (Investor)
Medtech Venture Partners (Investor)
FemHealth Ventures (Investor)